Serum Markers of Necrotizing Enterocolitis: A Systematic Review

Journal of Pediatric Gastroenterology and Nutrition

Volumn 65, Issue 6, 2017, Pages e120-e132

  Terrin, Gianluca ^a   Stronati, Laura ^a   Cucchiara, Salvatore ^a   De Curtis, Mario ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

C reactive protein; innate immunity; NEC; neonates; very low birth weight

Indexed keywords

APOLIPOPROTEIN C2; BIOLOGICAL MARKER; CALGRANULIN A; CALGRANULIN B; FATTY ACID BINDING PROTEIN 2; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; ISCHEMIA MODIFIED ALBUMIN; FABP2 PROTEIN, HUMAN; FATTY ACID BINDING PROTEIN; HUMAN SERUM ALBUMIN; ISCHEMIA-MODIFIED ALBUMIN;

DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INTESTINE TISSUE; MEDICAL SUBJECT HEADINGS; MEDLINE; NECROTIZING ENTEROCOLITIS; PRIORITY JOURNAL; REVIEW; SCOPUS; SENSITIVITY AND SPECIFICITY; SERUM; STAGING; SYSTEMATIC REVIEW; TISSUE INJURY; UNCERTAINTY; WEB OF SCIENCE; BLOOD; DISEASE EXACERBATION;

APOLIPOPROTEIN C-II; BIOMARKERS; CALGRANULIN A; DISEASE PROGRESSION; ENTEROCOLITIS, NECROTIZING; FATTY ACID-BINDING PROTEINS; HUMANS; INTERLEUKIN-10; SENSITIVITY AND SPECIFICITY; SERUM ALBUMIN, HUMAN;

EID: 85017172329     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0000000000001588     Document Type: Review

References (57)

1. Neu J, Walker WA. Necrotizing enterocolitis. N Engl J Med 2011;364:255-64.
2. Terrin G, Scipione A, De Curtis M. Update in pathogenesis and prospective in treatment of necrotizing enterocolitis. Biomed Res Int 2014;2014:543765.
3. Salvia G, Guarino A, Terrin G, et al. Neonatal onset intestinal failure: an Italian Multicenter Study. J Pediatr 2008;153:674-6.
4. Terrin G, Passariello A, Canani RB, et al. Minimal enteral feeding reduces the risk of sepsis in feed-intolerant very low birth weight newborns. Acta Paediatr 2009;98:31-5.
5. Walsh MC, Kliegman RM. Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin North Am 1986;33:179-201.
6. Bell MJ, Ternberg JL, Feigin RD, et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg 1978;187:1-7.
7. Lucchini R, Bizzarri B, Giampietro S, et al. Feeding intolerance in preterm infants. How to understand the warning signs. J Matern Fetal Neonatal Med 2011;24:72-4.
8. Passariello A, Terrin G, Baldassarre ME, et al. Diarrhea in neonatal intensive care unit. Word J Gastroenterol 2010;16:2664-8.
9. Ng PC, Ma TP, Lam HS. The use of laboratory biomarkers for surveillance, diagnosis and prediction of clinical outcomes in neonatal sepsis and necrotising enterocolitis. Arch Dis Child Fetal Neonatal Ed 2015;100:F448-52.
10. Evennett N, Alexander N, Petrov M, et al. A systematic review of serologic tests in the diagnosis of necrotizing enterocolitis. J Ped Surg 2009;44:2192-201.
11. Cheng S, Yu J, Zhou M, et al. Serologic intestinal fatty acid-binding protein in necrotizing enterocolitis diagnosis: a meta-analysis. BioMed Res Intern 2015;2015:156704.
12. Yang G, Wang Y, Jia X. Diagnostic value of intestinal fatty-acid-binding protein in necrotizing enterocolitis: a systematic review and metaanalysis. Indian J Pediatr 2016;83:1410-9.
13. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. PLoS Med 2008;6:e1000097.
14. Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 2011;155:529-36.
15. Terrin G, Passariello A, De Curtis M, et al. S100 A8/A9 protein as a marker for early diagnosis of necrotising enterocolitis in neonates. Arch Dis Child 2012;97:1102.
16. Rabinowitz SS, Dzakpasu P, Piecuch S, et al. Platelet-activating factor in infants at risk for necrotizing enterocolitis. J Pediatr 2001;138:81-6.
17. Lam HS, Wong SP, Cheung HM, et al. Early diagnosis of intraabdominal inflammation and sepsis by neutrophil CD64 expression in newborns. Neonatology 2011;99:118-24.
18. Lam HS, Cheung HM, Poon TC, et al. Neutrophil CD64 for daily surveillance of systemic infection and necrotizing enterocolitis in preterm infants. Clin Chem 2013;59:1753-60.
19. Turunen R, Andersson S, Nupponen I, et al. Increased CD11b-density on circulating phagocytes as an early sign of late-onset sepsis in extremely low-birth-weight infants. Pediatr Res 2005;57:270-5.
20. Remon J, Kampanatkosol R, Kaul RR, et al. Acute drop in blood monocyte count differentiates NEC from other causes of feeding intolerance. J Perinatol 2014;34:549-54.
21. Cetinkaya M, Ozkan H, Köksa N, et al. Comparison of the efficacy of serum amyloid A, C-reactive protein, and procalcitonin in the diagnosis and follow-up of necrotizing enterocolitis in premature infants. J Pediatr Surg 2011;46:1482-9.
22. Pourcyrous M, Korones SB, Yang W, et al. C-reactive protein in the diagnosis, management, and prognosis of neonatal necrotizing enterocolitis. Pediatrics 2005;116:1064-9.
23. Yakut I, Tayman C, Oztekin O, et al. Ischemia-modified albumin may be a novel marker for the diagnosis and follow-up of necrotizing enterocolitis. J Clin Lab Anal 2014;28:170-7.
24. Cetinkaya M, Ozkan H, Köksal N, et al. The efficacy of serial serum amyloid A measurements for diagnosis and follow-up of necrotizing enterocolitis in premature infants. Pediatr Surg Int 2010;26:835-41.
25. Ng PC, Ang IL, Chiu RW, et al. Host-response biomarkers for diagnosis of late-onset septicemia and necrotizing enterocolitis in preterm infants. J Clin Invest 2010;120:2989-3000.
26. Maheshwari A, Schelonka RL, Dimmitt RA, et al. Cytokines associated with necrotizing enterocolitis in extremely-low-birth-weight infants. Pediatr Res 2014;76:100-8.
27. Benkoe T, Reck C, Pones M, et al. Interleukin-8 predicts 60-day mortality in premature infants with necrotizing enterocolitis. J Pediatr Surg 2014;49:385-9.
28. Ng PC, Li K, Chui KM, et al. IP-10 is an early diagnostic marker for identification of late-onset bacterial infection in preterm infants. Pediatr Res 2007;61:93-8.
29. Edelson MB, Bagwell CE, Rozycki HJ. Circulating pro- and counterinflammatory cytokine levels and severity in necrotizing enterocolitis. Pediatrics 1999;103:766-71.
30. Aydemir C, Dilli D, Oguz SS, et al. Serum intestinal fatty acid bindingprotein level for early diagnosis and prediction of severity of necrotizing enterocolitis. Early Hum Dev 2011;87:659-61.
31. Edelson MB, Sonnino RE, Bagwell CE, et al. Plasma intestinal fatty acid binding protein in neonates with necrotizing enterocolitis: a pilot study. J Pediatr Surg 1999;34:1453-7.
32. Lieberman JM, Sacchettini J, Marks C, et al. Human intestinal fatty acid binding protein: report of an assay with studies in normal volunteers and intestinal ischemia. Surgery 1997;121:335-42.
33. Ng EW, Poon TC, Lam HS, et al. Gut-associated biomarkers L-FABP, I-FABP, and TFF3 and LIT score for diagnosis of surgical necrotizing enterocolitis in preterm infants. Ann Surg 2013;258:1111-8.
34. Schurink M, Kooi EM, Hulzebos CV, et al. Intestinal fatty acid-binding protein as a diagnostic marker for complicated and uncomplicated necrotizing enterocolitis: a prospective cohort study. PLoS One 2015;10: e0121336.
35. McLachlan R, Coakley J, Murton L, et al. Plasma intestinal alkaline phosphatase isoenzymes in neonates with bowel necrosis. J Clin Pathol 1993;46:654-9.
36. Evennett N, Cerigioni E, Hall NJ, et al. Smooth muscle actin as a novel serologic marker of severe intestinal damage in rat intestinal ischemiareperfusion and human necrotising enterocolitis. J Surg Res 2014;191:323-30.
37. Stríz I, Trebichavský I. Calprotectin a pleiotropic molecule in acute and chronic inflammation. Physiol Res 2004;53:245-53.
38. Berni Canani R, Rapacciuolo L, Romano MT, et al. Diagnostic value of faecal calprotectin in paediatric gastroenterology clinical practice. Dig Liver Dis 2004;36:467-70.
39. Terrin G, Passariello A, Manguso F, et al. Serum calprotectin: an antimicrobial peptide as a new marker for the diagnosis of sepsis in very low birth weight newborns. Clin Dev Immunol 2011;2011:291085.
40. Hanahan DJ. Platelet activating factor: a biologically active phosphoglyceride. Ann Rev Biochem 1986;55:483-509.
41. Caplan MS, Sun XM, Hseuh W, et al. Role of platelet activating factor and tumor necrosis factor-alpha in neonatal necrotizing enterocolitis. J Pediatr 1990;116:960-4.
42. Elghetany MT. Surface antigen changes during normal neutrophilic development: a critical review. Blood Cells Mol Dis 2002;28:260e74.
43. Philip AG, Sann L, Bienvenu F. Acute phase proteins in neonatal necrotizing enterocolitis. Acta Paediatr Scand 1986;75:1032-3.
44. Arnon S, Litmanovitz I, Regev RH, et al. Serum amyloid A: an early and accurate marker of neonatal early-onset sepsis. J Perinatol 2007;27:297-302.
45. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448-54.
46. Guthmann F, Börchers T, Wolfrum C, et al. Plasma concentration of intestinal- and liver-FABP in neonates suffering from necrotizing enterocolitis and in healthy preterm neonates. Mol Cell Biochem 2002;239:227-34.
47. Relja B, Szermutzky M, Henrich D, et al. Intestinal-FABP and liver- FABP: novel markers for severe abdominal injury. Acad Emerg Med 2010;17:729-35.
48. Pelsers MM, Hermens WT, Glatz JF. Fatty acid-binding proteins as plasma markers of tissue injury. Clin Chim Acta 2005;352:15-35.
49. Hoffmann W, Jagla W, Wiede A. Molecular medicine of TFF-peptides: from gut to brain. Histol Histopathol 2001;16:319-34.
50. Rosato FE, Lazitin L, Miller LD, et al. Changes in intestinal alkaline phosphatase in bowel ischemia. Am J Surg 1971;121:289-92.
51. Reisinger KW, Van der Zee DC, Brouwers HA, et al. Noninvasive measurement of fecal calprotectin and serum amyloid A combined with intestinal fatty acid-binding protein in necrotizing enterocolitis. J Pediatr Surg 2012;47:1640-5.
52. Josefsson S, Bunn SK, Domellof M. Fecal calprotectin in very low birth weight infants. J Pediatr Gastroenterol Nutr 2007;44:407-13.
53. Pergialiotis V, Kostantopoulos P, Karampetsou N, et al. Calprotectin in necrotizing enterocolitis: a systematic review of the literature. Inflamm Res 2016;65:847-52.
54. Yikilmaz A, Hall NJ, Daneman A, et al. Prospective evaluation of the impact of sonography on the management and surgical intervention of neonates with necrotizing enterocolitis. Pediatr Surg 2014;30:1231-40.
55. Stone ML, Tatum PM, Weitkamp JH, et al. Abnormal heart rate characteristics before clinical diagnosis of necrotizing enterocolitis. J Perinatol 2013;33:847-50.
56. Canani RB, Romano MT, Greco L, et al. Effects of disease activity on anti-Saccharomyces cerevisiae antibodies: implications for diagnosis and follow-up of children with Crohn's disease. Inflamm Bowel Dis 2004;10:234-9.
57. Ng PC, Ma TP, Lam HS. The use of laboratory biomarkers for surveillance, diagnosis and prediction of clinical outcomes in neonatal sepsis and necrotizing enterocolitis. Arch Dis Child Fetal Neonatal Ed 2015;100:F448-52.